Law ❯ Litigation ❯ Securities Class Action ❯ Investor Rights

Corporate Accountability

Law Firms Press MoonLake Class Action Over SLK Claims as Lead‑Plaintiff Deadline Nears

The SDNY case is in its early stages following allegations that MoonLake overstated sonelokimab’s edge over BIMZELX.

Telix Hit With Securities Class Action Over Prostate-Drug Claims and Supply Chain Assurances

MoonLake Investors Get Deadline Reminder as Securities Suits Mount Over Sonelokimab Trial